The burgeoning field of obesity management has witnessed remarkable advancements with the emergence of dual GLP-3 receptor agonists, notably Retatrutide and Trizepatide. These innovative therapies represent a https://alyshaavhf506860.sasugawiki.com/7549207/glp_3_receptor_agonists_retatrutide_trizepatide